Viewing Study NCT01431794


Ignite Creation Date: 2025-12-25 @ 1:38 AM
Ignite Modification Date: 2025-12-26 @ 4:03 PM
Study NCT ID: NCT01431794
Status: TERMINATED
Last Update Posted: 2020-01-22
First Post: 2011-07-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization: